Skip to main content
Clinical Trials/IRCT201411033566N7
IRCT201411033566N7
Completed
Phase 3

Comparison of therapeutic effect of oral and topical tranexamic acid in the treatment of patients with facial melasma receiving topical hydroquinone

Vice chancellor for research, Tabriz University of Medical Sciences0 sites90 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Melasma.
Sponsor
Vice chancellor for research, Tabriz University of Medical Sciences
Enrollment
90
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Tabriz University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusion criterion:patients with facial melasma; patients between 20 and 70 years old. Exclusion criteria: pregnancy; underlying skin diseases; thyroid disease; history of drug allergy; previous use of contraceptives or phenytoin; patients with uncontrolled hypertension; patients with skin infections such as Impetigo; a history of coagulation or thrombosis; skin peeling treatments to treat existing disease; persons aged less than 20 years and more than 70 years old.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials